DETECTION OF CEREBRAL ATROPHY IN TYPE- II DIABETES MELLITUS BY MAGNETIC RESONANCE IMAGING OF BRAIN
AbstractBackground: Diabetes is a metabolic disorder that affects many systems in the body. Cerebralatrophy is one of the complications of diabetes and research is on going to find out itsaetiopathological factors. The main aim of the study was to determine the frequency of cerebralatrophy in type-II diabetes mellitus using magnetic resonance imaging of the brain. Methods: Onehundred diabetic patients (Random blood sugar >126 mg/dl) were recruited in this study after theinformed consent from every patient. Duration of diabetes was five years and more in all the patientsas determined by their glycosylated haemoglobin which was >6 in all the patients. All the patientswere undergone MRI of brain using 1.5 Tesla power magnetic resonance imaging machine of PickerCompany. Evan’s index, a specific parameter for measurement of cerebral atrophy was calculated onMR images and was used in this study. Results: In male group the frequency of cerebral atrophy was22 (47%) and in female group it was found to be 23 (43%). When we study the overall populationthe frequency was found to be 45 (45%). The results are well in concordance with the previous datapublished on this issue. Conclusions: Cerebral atrophy, a complication of long standing diabetes isquite frequent in our population and is well diagnosed by MRI.Keywords: Diabetes Mellitus, cerebral atrophy, MRI, frequency, complications of diabetes
Brant-Zawadzki M, Heiserman JE. The roles of MR
angiography, CT angiography, and sonography in vascular
imaging of the head and neck. AJNR Am J Neuroradiol
Hoeffner EG, Case I, Jain R, Gujar SK, Shah GV, Deveikis JP,
et al. Cerebral perfusion CT: technique and clinical
applications. Radiology 2004;231:632–44.
Provenzale JM, Shah K, Patel U, McCrory DC. Systematic
review of CT and MR perfusion imaging for assessment of
acute cerebrovascular disease. AJNR Am J Neuroradiol
Pretorius PM, Quaghebeur G. The role of MRI in the
diagnosis of MS. Clin Radiol 2003;58:434–48.
Araki Y, Nomura M, Tanaka H, Yamamoto H, Tsukaguchi I,
Nakamura H. MRI of the brain in diabetes mellitus.
Inoue T, Fushimi H, Yamada Y, Udaka F, Kameyama M:
Asymptomatic multiple lacunae in diabetics and non-diabetics
detected by brain magnetic resonance imaging. Diabetes Res
Clin Pract 1996;31:81–6.
Kameyama M, Fushimi H, Udaka F. Diabetes mellitus and
cerebral vascular disease. Diabetes Res Clin Pract
Shintani S, Shiigai T, Arinami T: Subclinical cerebral lesion
accumulation on serial magnetic resonance imaging (MRI) in
patients with hypertension: risk factors. Acta Neurol Scand
Lunetta M, Damanti AR, Fabbri G, Lombardo M, DiMauro M,
Mughini L. Evidence by magnetic resonance imaging of
cerebral alterations of atrophy type in young insulin-dependent
diabetic patients. J Endocrinol Inves 1994;17:241–5.
Fushimi H, Inoue T, Yamada Y, Udaka F, Kameyama M.
Asymptomatic cerebral infarcts (lacunae), their risk factors and
intellectual disturbances. Diabetes 1996;45(Suppl 3):S98–100.
Fukuda H, Kitani M. Differences between treated and untreated
hypertensive subjects in the extent of periventricular
hyperintensities observed on brain MRI. Stroke 1995;26:1593–7.
Perros P, Deary IJ, Sellar RJ, Best JJ, Frier BM. Brain
abnormalities demonstrated by magnetic resonance imaging in
adult patients with and without a history of severe
hypoglycemia. Diabetes Care 1997;20:1013–8.
Moulin T, Tatu L, Vuillier F, Berger E, Chavot D, Rumbach L.
Role of a stroke data bank in evaluating cerebral infarction
subtypes: patterns and outcome of 1,776 consecutive patients
from the Besancon stroke registry. Cerebrovasc Dis
Bradley WG Jr, Waluch V, Brant-Zawadzki M, Yadley RA,
Wycoff RR. Patchy periventricular white matter lesions in the
elderly: a common observation during NMR imaging.
Noninvasive Med Imaging 1984;1:35–41.
Awad IA, Spetzler RF, Hodak JA, Awad CA, Carey R.
Incidental subcortical lesions identified on magnetic resonance
imaging in the elderly. I. Correlation with age and
cerebrovascular risk factors. Stroke 1986;17:1084–9.
Sarpel G, Chaudry F, Hindo W. Magnetic resonance imaging
periventricular hyperintensity in a veterans administration
hospital population. Arch Neurol 1987;44:725–728.
Kertesz A, Black SE, Tokar G, Benke T, Carr T, Nicholson L.
Periventricular and subcortical hyperintensities on magnetic
resonance imaging: rims, caps and unidentified bright objects.
Arch Neurol 1988;45:404–8.
Schmidt R, Fazekas F, Kleinert G, Offenbacher H, Gindl K,
Payer F, et al. Magnetic resonance imaging signal
hyperintensities in the deep and subcortical white matter: a
comparative study between stroke patients and normal
volunteers. Arch Neurol 1992;49:825–7.
Hendrie HC, Farlow MR, Austrom MG, Edwards MK,
Williams MA. Foci of increased T2 signal intensity on brain
MRI scans of healthy elderly subjects. AJNR Am J
Bots ML, vanSwieten JC, Breteler MMB, de Jong PT, van Gijn
J, Hofman A, Grobbee DE: Cerebral white matter lesions and
atherosclerosis in the Rotterdam study. Lancet 1993;341:1232–7.
Longstreth WT, Bernick C, Manolio TA, Bryan N, Jungreis
CA, Price TR. Lacunar infarcts defined by magnetic resonance
imaging of 3660 elderly people: the Cardiovascular Health
Study. Arch Neurol 1998;55:1217–25.
Longstreth WT, Manolio TA, Arnold A, Burke GL, Bryan N,
Jungreis CA, et al. Clinical correlates of white matter findings
on cranial magnetic resonance imaging of 3301 elderly people:
the Cardiovascular Health Study. Stroke 1996;23:1274–82.
Longstreth WT, Arnold A, Manolio TA, Burke GL, Bryan N,
Jungreis CA, et al. Clinical correlates of ventricular and sulcal
size on cranial magnetic resonance imaging of 3,301 elderly
people: the Cardiovascular Health Study Collaborative
Research Group. Neuroepidemiology 2000;19:30–42.
Schmidt R, Fazekas F, Kapeller P, Schmidt H, Hartung HP.
MRI white matter hyperintensities-three-year follow-up of the
Austrian Stroke Prevention Study. Neurology 1999;53:132–9.
UK Prospective Diabetes Study Group. Tight blood pressure
control and risk of macrovascular and microvascular
complications in type 2 diabetes: UKDPS 38. Br Med J
Finn R. MRI reveals cerebral atrophy in type 1 diabetic
patients. Clinical Psychiatry News, July 2003. Available from:
Schmidt R, Launer LJ, Nilsson LG, Pajak A, Sans S, Berger K,
Breteler MM, et al. Magnetic Resonance Imaging of the Brain
in Diabetes The Cardiovascular Determinants of Dementia
(CASCADE) Study. Diabetes 2004;53:687–92.